Auxilius, a NYC-based provider of clinical trial financial management (CTFM) software, raised $10M in funding.
The round was led by SignalFire.
The company intends to use the funds to expand operations and development efforts.
Led by CEO Adam Weisman, and Erin Warner Guill, Auxilius provides solutions for biopharma companies to tackle the operational, financial, and accounting needs of clinical trials. The company has built FP&A and accounting software that replaces manual processes and allows sponsors to take control over trial costs and clinical vendors through study-level budgeting, planning and financial close. Currently, the company works with over 50 sponsors including emerging Biotech and mature, public Pharma. New customers who came on board in 2023 include Trevi Therapeutics, TG Therapeutics, Invivyd and Repare.
FinSMEs
12/06/2024